Parallel Health World News Logo
update

Parallel Health World

cropper
update
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
February 27.2025
2 Minutes Read

Understanding the Rising Costs of VA's Oracle EHR Project: What It Means for Veterans

Department of Veterans Affairs seal on polished wood panel.

Rising Costs and Project Delays: What VA's Oracle EHR Means for Veterans

As the Department of Veterans Affairs (VA) grapples with its electronic health record (EHR) modernization project, recent testimonies indicate a pressing need for a revised cost estimate that reflects the changing landscape of the initiative. Current projections range from the VA's earlier estimate of approximately $16 billion to an independent assessment that could be as high as $50 billion, highlighting the uncertainty surrounding the rollout of Oracle's new health record system across its facilities.

Understanding the Financial Implications

The cost disparities are stark: the initial 2019 budget has become 'severely outdated and incomplete,' as highlighted by Carol Harris from the Government Accountability Office (GAO). With the VA already investing about $12.7 billion into the initiative, lawmakers like Rep. Tom Barrett emphasize the necessity of being budget cognizant while ensuring the project's successful execution. "Cost of this is an unknown at this point," he stated, reflecting a common sentiment among stakeholders who are keen to avoid budgetary pitfalls.

Barriers to Implementation: The Project's Hurdles

The rollout has faced significant obstacles since Cerner was awarded the contract in 2018, aimed at replacing an aging medical record system. Since the first deployment at Mann-Grandstaff VA Medical Center two years later, user adoption has been sluggish with only 6 out of 170 facilities currently operational with Oracle's system. This has led to criticisms surrounding technology reliability and patient safety concerns, underscoring that the path forward is fraught with challenges.

Future Outlook: What Lies Ahead for the EHR Project?

Looking to the future, the VA has plans to resume the EHR deployment at four facilities in Michigan, but experts warn it is unrealistic to expect completion across the remaining facilities by the time the current Oracle contract expires in 2028. With the pace of technological innovation in healthcare, many are wondering how this will ultimately impact patient care and electronic management of health records.

While Oracle executives argue that recent improvements to the system can lead to reduced costs and a quicker rollout, challenges including job cuts and the departure of key staff at the VA may complicate these efforts. As the agency works towards a comprehensive master schedule for deployment, it is clear that the financial and operational implications of this endeavor will remain at the forefront of discussions for years to come.

Finance and Health

25 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
05.29.2026

CVS Fights Back: The State of Pharmacy Benefit Manager Regulation in Tennessee

Update CVS Launches Legal Battle Against New Tennessee Pharmacy Law CVS Health has set the stage for a significant legal showdown in Tennessee, as the company files a lawsuit challenging the recently enacted Freedom, Access and Integrity in Registered Pharmacy (FAIR Rx) Act. This law prohibits pharmacy benefit managers (PBMs) from owning pharmacies within the state, a move CVS argues unfairly restricts competition. Impact of the FAIR Rx Act: A Threat to Accessibility? CVS’s lawsuit details the potential repercussions of the FAIR Rx Act, claiming it threatens to close 136 of its pharmacies and lead to the layoffs of about 2,000 employees. Despite the law's intent to bolster independent pharmacies, CVS contends it will severely limit access to affordable medications for nearly 1.5 million patients in Tennessee. The company posits that an increase in drug costs could exceed $180 million annually for local employers, raising serious questions about the law's implications for healthcare access and affordability. The Legal Landscape: A Trend or a Tipping Point? Tennessee follows Arkansas as the second state to enact such a law, highlighting a growing trend among states to regulate PBM ownership of pharmacies. However, CVS's legal challenge underscores a larger conflict brewing between state efforts to protect local businesses and the constitutional rights concerning interstate commerce. The Dormant Commerce Clause is at the heart of CVS’s argument, suggesting that Tennessee's law creates an unfair barrier for out-of-state competitors while favoring local pharmacy operations. Bipartisan Support: A Double-Edged Sword? Despite the fierce lobbying efforts from PBMs, including a reported spending of over $7 million against the bill, the FAIR Rx Act secured broad bipartisan support. Tennessee lawmakers believe this legislation serves the best interests of their constituents, aiming to bolster local pharmacies and enhance patient choice. Meanwhile, CVS argues that rather than fostering competition, the law ultimately restricts it, creating a protected market that undermines consumer options. What Lies Ahead: The Broader Implications The outcome of CVS's lawsuit may carry significant weight beyond Tennessee, influencing similar legislative initiatives across the nation. As healthcare access remains a paramount concern for consumers, the tension between market forces and regulatory actions continues to shape the pharmaceutical landscape. This case not only underscores the complexities of pharmaceutical economics but also reflects shifting dynamics in how states navigate relationships with major healthcare players. Takeaway: The Consumer Perspective For Tennessee residents and beyond, the implications of this lawsuit and the FAIR Rx Act go beyond corporate competition; they dive into the heart of healthcare accessibility and affordability. As consumers, awareness of these legal battles is paramount, as they will directly impact which medications you can access and at what cost.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*